Accession Number: | 0001209191-21-024631 |
Date: | 2021-03-29 |
Issuer: | ASSEMBLY BIOSCIENCES, INC. (ASMB) |
Original Submission Date: |
OKAZAKI JASON A
C/O ASSEMBLY BIOSCIENCES, INC.
331 OYSTER POINT BLVD, FOURTH FLOOR
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-03-29 | A | 13,750 | a | $0.00 | 67,250 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 4.33 | 2021-03-29 | deemed execution date | A | 82,500 (a) | 2031-03-29 | common stock 82,500 | $4.33 | 82,500 | direct |
ID | footnote |
---|---|
f1 | grant of restricted stock units. the restricted stock units vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: march 29, 2022; march 29, 2023; march 29, 2024; and march 29, 2025. |
f2 | includes 1,000 shares acquired under the assembly biosciences, inc. 2018 employee stock purchase plan on november 14, 2020. |
f3 | grant of stock options. the stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, march 29, 2022; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on march 29, 2025. |